Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/10/770
Active ingredient: 1-[2-(Benzo[1,2,5]thiadiazol-5-ylamino)-6-(2,6-dichloro-phenyl)-pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butyl-urea
Indication: Treatment of acute myeloid leukaemia
Sponsor: Sanofi-Aventis groupe
54 rue La Boétie, 75008 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/09/2010 Orphan designation EMA/OD/023/10 (2010)6637 of 20/09/2010
06/11/2012 Change of name and/or address of sponsor EMA/OD/023/10
24/10/2014 Removal of orphan designation from Community Register